Zesergio Melo

507 total citations
21 papers, 403 citations indexed

About

Zesergio Melo is a scholar working on Molecular Biology, Nephrology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Zesergio Melo has authored 21 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Nephrology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Zesergio Melo's work include Ion Transport and Channel Regulation (5 papers), Ion channel regulation and function (4 papers) and Anesthesia and Neurotoxicity Research (3 papers). Zesergio Melo is often cited by papers focused on Ion Transport and Channel Regulation (5 papers), Ion channel regulation and function (4 papers) and Anesthesia and Neurotoxicity Research (3 papers). Zesergio Melo collaborates with scholars based in Mexico, France and United States. Zesergio Melo's co-authors include Raquel Echavarría, Gerardo Gamba, Norma Vázquez, Adriana Mercado, Lorena Rojas‐Vega, María Chávez‐Canales, Juliette Hadchouel, Silvana Bazúa‐Valenti, Consuelo Plata and Eduardo R. Argaiz and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The FASEB Journal.

In The Last Decade

Zesergio Melo

20 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zesergio Melo Mexico 12 255 92 84 75 46 21 403
Ganesh Pathare Germany 15 260 1.0× 85 0.9× 79 0.9× 146 1.9× 17 0.4× 22 430
Ira Kurtz United States 13 216 0.8× 128 1.4× 34 0.4× 122 1.6× 17 0.4× 19 452
Mohammed Z. Ferdaus United States 13 357 1.4× 131 1.4× 129 1.5× 94 1.3× 15 0.3× 31 516
Georgina Carr United Kingdom 12 315 1.2× 142 1.5× 37 0.4× 54 0.7× 85 1.8× 14 551
Anne Debonneville Switzerland 14 472 1.9× 121 1.3× 93 1.1× 25 0.3× 36 0.8× 21 621
Silvana Bazúa‐Valenti Mexico 11 316 1.2× 116 1.3× 125 1.5× 96 1.3× 15 0.3× 13 418
Birgül Özkesici Kurt Germany 14 226 0.9× 108 1.2× 16 0.2× 67 0.9× 16 0.3× 31 545
Saqib Qureshi United Kingdom 10 143 0.6× 37 0.4× 76 0.9× 30 0.4× 14 0.3× 13 537
Ivana Pela Italy 10 279 1.1× 47 0.5× 24 0.3× 59 0.8× 68 1.5× 19 473
Pascale Borensztein France 12 313 1.2× 99 1.1× 36 0.4× 119 1.6× 22 0.5× 28 471

Countries citing papers authored by Zesergio Melo

Since Specialization
Citations

This map shows the geographic impact of Zesergio Melo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zesergio Melo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zesergio Melo more than expected).

Fields of papers citing papers by Zesergio Melo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zesergio Melo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zesergio Melo. The network helps show where Zesergio Melo may publish in the future.

Co-authorship network of co-authors of Zesergio Melo

This figure shows the co-authorship network connecting the top 25 collaborators of Zesergio Melo. A scholar is included among the top collaborators of Zesergio Melo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zesergio Melo. Zesergio Melo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Melo, Zesergio, Eliseo Portilla‐de Buen, Bibiana Moreno-Carranza, et al.. (2023). Pharmacological Blockade of TGF-Beta Reduces Renal Interstitial Fibrosis in a Chronic Ischemia–Reperfusion Animal Model. MDPI (MDPI AG). 2(1). 137–147. 4 indexed citations
3.
Noriega, Lilia G., Zesergio Melo, Renuga Devi Rajaram, et al.. (2021). SIRT7 modulates the stability and activity of the renal K‐Cl cotransporter KCC4 through deacetylation. EMBO Reports. 22(5). e50766–e50766. 14 indexed citations
4.
Echavarría, Raquel, et al.. (2021). Sex Differences in Renal Function: Participation of Gonadal Hormones and Prolactin. SHILAP Revista de lepidopterología. 2(3). 185–202. 7 indexed citations
5.
Buen, Eliseo Portilla‐de, Zesergio Melo, Jorge Andrade‐Sierra, et al.. (2021). Impact of transplantation on neutrophil extracellular trap formation in patients with end-stage renal disease. Medicine. 100(27). e26595–e26595. 4 indexed citations
6.
Echavarría, Raquel, et al.. (2020). Opioid Preconditioning Modulates Repair Responses to Prevent Renal Ischemia-Reperfusion Injury. Pharmaceuticals. 13(11). 387–387. 9 indexed citations
7.
Melo, Zesergio, et al.. (2020). Diagnostic, Prognostic, and Therapeutic Value of Non-Coding RNA Expression Profiles in Renal Transplantation. Diagnostics. 10(2). 60–60. 6 indexed citations
8.
Melo, Zesergio, et al.. (2020). Sex-dependent mechanisms involved in renal tolerance to ischemia-reperfusion: Role of inflammation and histone H3 citrullination. Transplant Immunology. 63. 101331–101331. 12 indexed citations
9.
Echavarría, Raquel, et al.. (2020). Anesthetic preconditioning increases sirtuin 2 gene expression in a renal ischemia reperfusion injury model. Minerva Urologica e Nefrologica. 72(2). 243–249. 13 indexed citations
10.
Melo, Zesergio, et al.. (2020). Urinary expression of long non‑coding RNA TUG1 in non‑diabetic patients with glomerulonephritides. Biomedical Reports. 14(1). 17–17. 13 indexed citations
11.
Echavarría, Raquel, et al.. (2019). Opioids Preconditioning Upon Renal Function and Ischemia-Reperfusion Injury: A Narrative Review. Medicina. 55(9). 522–522. 13 indexed citations
12.
Melo, Zesergio, et al.. (2019). Neutrophil Extracellular Traps in the Establishment and Progression of Renal Diseases. Medicina. 55(8). 431–431. 34 indexed citations
13.
Melo, Zesergio, Ximena Castillo, Bibiana Moreno-Carranza, et al.. (2019). Vasoinhibin Suppresses Nerve Growth Factor-Induced Differentiation and Survival of PC12 Pheochromocytoma Cells. Neuroendocrinology. 109(2). 152–164. 5 indexed citations
14.
Melo, Zesergio, et al.. (2018). Novel Roles of Non-Coding RNAs in Opioid Signaling and Cardioprotection. Non-Coding RNA. 4(3). 22–22. 19 indexed citations
15.
Castillo, Ximena, Zesergio Melo, Alfredo Varela‐Echavarría, et al.. (2017). Vasoinhibin Suppresses the Neurotrophic Effects of VEGF and NGF in Newborn Rat Primary Sensory Neurons. Neuroendocrinology. 106(3). 221–233. 18 indexed citations
16.
Mercado, Adriana, Paola de los Heros, Zesergio Melo, et al.. (2016). With no lysine L-WNK1 isoforms are negative regulators of the K+-Cl cotransporters. American Journal of Physiology-Cell Physiology. 311(1). C54–C66. 10 indexed citations
17.
Mercado, Adriana, Zesergio Melo, Armando R. Tovar, et al.. (2015). The K + :Cl Cotransporter KCC4 is Activated by Deacetylation Induced by the Sirtuin7 (SIRT7). The FASEB Journal. 29(S1). 2 indexed citations
18.
Bazúa‐Valenti, Silvana, María Chávez‐Canales, Lorena Rojas‐Vega, et al.. (2014). The Effect of WNK4 on the Na+–Cl− Cotransporter Is Modulated by Intracellular Chloride. Journal of the American Society of Nephrology. 26(8). 1781–1786. 131 indexed citations
19.
Melo, Zesergio, Paola de los Heros, Silvia Cruz‐Rangel, et al.. (2013). N-terminal Serine Dephosphorylation Is Required for KCC3 Cotransporter Full Activation by Cell Swelling. Journal of Biological Chemistry. 288(44). 31468–31476. 31 indexed citations
20.
Cruz‐Rangel, Silvia, Zesergio Melo, Norma Vázquez, et al.. (2011). Similar effects of all WNK3 variants on SLC12 cotransporters. American Journal of Physiology-Cell Physiology. 301(3). C601–C608. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026